The University of Southampton
University of Southampton Institutional Repository

Managing acne vulgaris: an update

Managing acne vulgaris: an update
Managing acne vulgaris: an update
Acne vulgaris is very common and can have significant negative impact on people. While sometimes a transient problem, acne may persist for many years and often leads to permanent scars or pigment changes. Guidelines unanimously advise topical treatments as first-line, although differ in recommending either topical benzoyl peroxide or topical retinoid (mainly adapalene) alone or in combination. Guidance published by the National Institute for Health and Care Excellence advises counselling patients regarding avoidance of skin irritation when starting topical treatments and promoting adherence (treatments take 6–8 weeks to work). Oral antibiotics are currently overprescribed for acne but have a role when coprescribed with a non-antibiotic topical treatment. Hormonal treatments, such as the combined contraceptive pill, are also effective and there is growing evidence for the use of spironolactone for women with persistent acne. Recent guidance from the Medicines and Healthcare products Regulatory Agency regarding isotretinoin has implications for specialist prescribing and monitoring, and increasing public awareness of potential risks of mental health problems and sexual dysfunction. Although acne is associated with psychiatric disorder, the mental health effects of isotretinoin remain controversial.
acne vulgaris, antimicrobial stewardship, primary health care, skin disease, Antimicrobial Stewardship, Skin diseases, Primary Health Care
0012-6543
6-10
Santer, Miriam
3ce7e832-31eb-4d27-9876-3a1cd7f381dc
Burden-Teh, Esther
9477da01-4541-4ddd-ab0b-7d20973f914b
Ravenscroft, Jane
c04b5faa-bcd0-4d5d-a5ff-44b3342e4ced
Santer, Miriam
3ce7e832-31eb-4d27-9876-3a1cd7f381dc
Burden-Teh, Esther
9477da01-4541-4ddd-ab0b-7d20973f914b
Ravenscroft, Jane
c04b5faa-bcd0-4d5d-a5ff-44b3342e4ced

Santer, Miriam, Burden-Teh, Esther and Ravenscroft, Jane (2023) Managing acne vulgaris: an update. Drug and Therapeutics Bulletin, 62 (1), 6-10. (doi:10.1136/dtb.2023.000051).

Record type: Review

Abstract

Acne vulgaris is very common and can have significant negative impact on people. While sometimes a transient problem, acne may persist for many years and often leads to permanent scars or pigment changes. Guidelines unanimously advise topical treatments as first-line, although differ in recommending either topical benzoyl peroxide or topical retinoid (mainly adapalene) alone or in combination. Guidance published by the National Institute for Health and Care Excellence advises counselling patients regarding avoidance of skin irritation when starting topical treatments and promoting adherence (treatments take 6–8 weeks to work). Oral antibiotics are currently overprescribed for acne but have a role when coprescribed with a non-antibiotic topical treatment. Hormonal treatments, such as the combined contraceptive pill, are also effective and there is growing evidence for the use of spironolactone for women with persistent acne. Recent guidance from the Medicines and Healthcare products Regulatory Agency regarding isotretinoin has implications for specialist prescribing and monitoring, and increasing public awareness of potential risks of mental health problems and sexual dysfunction. Although acne is associated with psychiatric disorder, the mental health effects of isotretinoin remain controversial.

Text
Acne_review_for_DTB_clean_copy - Accepted Manuscript
Download (83kB)
Text
6.full - Version of Record
Download (199kB)

More information

Accepted/In Press date: 2023
e-pub ahead of print date: 27 December 2023
Published date: 27 December 2023
Additional Information: Publisher Copyright: © 2023 BMJ Publishing Group. All rights reserved. © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Keywords: acne vulgaris, antimicrobial stewardship, primary health care, skin disease, Antimicrobial Stewardship, Skin diseases, Primary Health Care

Identifiers

Local EPrints ID: 485760
URI: http://eprints.soton.ac.uk/id/eprint/485760
ISSN: 0012-6543
PURE UUID: 57bb9fa7-a191-43c8-bb85-e29114cbfe6a
ORCID for Miriam Santer: ORCID iD orcid.org/0000-0001-7264-5260

Catalogue record

Date deposited: 18 Dec 2023 20:35
Last modified: 06 Jun 2024 01:47

Export record

Altmetrics

Contributors

Author: Miriam Santer ORCID iD
Author: Esther Burden-Teh
Author: Jane Ravenscroft

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×